Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Better Buy: Gilead Sciences vs. Berkshire Hathaway

By Max Macaluso and Patrick Morris - Mar 22, 2014 at 10:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

We've collected the most popular companies amongst Fool.com readers and put them head-to-head in a good old-fashioned challenge we're calling The Motley Fool's Better Buy Tournament.

In today's ­second-round match-up of The Motley Fool's Better-Buy Tournament, Gilead Sciences squares off against Berkshire Hathaway in a battle to determine which stock is the better buy now. The 64-company tournament pits two Motley Fool analysts against each other as they make the case for their stocks, with the winner determined by you, the readers.

Motley Fool analyst Max Macaluso makes the case for Gilead Sciences ( GILD -2.44% ) to move on to the next round. Gilead is one of today's biggest biotech companies and has a number of blockbuster drugs already on the market. It also recently launched a potential blockbuster, Sovaldi, which is a new medication for the treatment of hepatitis C, and its impressive pipeline also bodes well for the company's future.

Berkshire Hathaway ( BRK.A -1.97% )( BRK.B -1.93% ) is managed by one of the greatest investors ever in Warren Buffett, and it should always be considered when discussing the best buys, according to Motley Fool analyst Patrick Morris. Of course, beyond its remarkable management team, there's also the reality of its diverse collection of businesses, from insurance to energy to railways and financial services.

Considering that earnings available to its shareholders of $19.5 billion in 2013 nearly doubled the $10.3 billion seen just two years ago, this is a great investment consideration. 

Watch these analysts square off in the following video, and then vote for a winner. Then check out the other companies in The Motley Fool's Better-Buy Bracket

This year's winning stock?
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Cast your vote in the poll below the video!

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Berkshire Hathaway Inc. Stock Quote
Berkshire Hathaway Inc.
BRK.A
$416,876.00 (-1.97%) $-8,384.00
Berkshire Hathaway Inc. Stock Quote
Berkshire Hathaway Inc.
BRK.B
$276.69 (-1.93%) $-5.43
Gilead Sciences, Inc. Stock Quote
Gilead Sciences, Inc.
GILD
$68.93 (-2.44%) $-1.72

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
673%
 
S&P 500 Returns
142%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/01/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.